Document is current
Any future updates will be listed below
-
Authors
Hadzijusufovic, E https://orcid.org/0000-0001-7409-4204
Albrecht-Schgoer, K
Huber, K https://orcid.org/0000-0002-1103-5300
Hoermann, G
Grebien, F https://orcid.org/0000-0003-4289-2281
Eisenwort, G
Schgoer, W
Herndlhofer, S
Kaun, C
Theurl, M
Sperr, W R
Rix, U https://orcid.org/0000-0002-8242-2770
Sadovnik, I
Jilma, B
Schernthaner, G H
Wojta, J
Wolf, D
Superti-Furga, G https://orcid.org/0000-0002-0570-1768
Kirchmair, R
Valent, P
- License Information
-
More Information
Article History
Received: 22 April 2017
Revised: 13 July 2017
Accepted: 17 July 2017
First Online: 31 July 2017
Competing interests
: EH received honoraria from Novartis. GHS received honoraria from Amgen, Astra Zeneca, Boehringer Ingelheim, BMS, Elli Lilly, Merck, Novo-Nordisk, Novartis, Pfizer and Sanofi-Aventis. DW received honoraria from Pfizer, BMS, Novartis, and Ariad and Research Grants from Pfizer and Ariad. RK received honoraria from Ariad and a Research Grant from Ariad. GH received honoraria form Novartis and Ariad. PV received honoraria from Novartis, Celgene, Pfizer, Deciphera, BMS, Ariad, and Incyte; and research grants from Novartis, Deciphera and Ariad. The remaining authors declare no conflict of interest.
